MENU
PSNL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Personalis (PSNL) Ownership - Who owns Personalis?

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies... Show more

Profile

Industry
N/A
Address
6600 Dumbarton Circle
Phone
+1 650 752-1300
Employees
225
Web
https://www.personalis.com

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
464.67M
P/E Ratio
N/A
Total Cash
173.23M
Projected Growth
N/A
Total Debt
42.44M
Revenue
80.32M
Risk (Beta)
2.00
Dividend Yield
N/A
Total Cash/Share
1.95
Total Debt/Equity
N/A
Revenue/Share
1.04 USD as % of share price

Fundamentals

PSNL
Capitalization
465M
P/E Ratio
N/A
Risk (Beta)
2.00
Dividend Yield
N/A
Total Cash
173M
Total Cash/Share
1.95
Total Debt
42.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.04%
Revenue
80.3M
ROE
N/A
Book Value
191M
P/B Ratio
2.43
Cash Flow
N/A
Earnings
-1.28
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
6.09
Current Revenue Per Employee
75122.27
Dividends Per Share - Security
N/A
EBITDA
-80.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
27.65
Revenue To Assets
-41.12
Shares Held By Institutions
554M
Shares Outstanding - Current
88.7M
Total Liabilities
67.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-9.343
View a ticker or compare two or three
PSNL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PSNL showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies.

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
6600 Dumbarton Circle
Phone
+1 650 752-1300
Employees
225
Web
https://www.personalis.com